Clinical Research Directory

Inclusion Criteria: 1\. Adult patients ≥18 years who are newly referred to the outpatient Adult Leukemia Treatment Program with the following diagnoses: 1. Acute myeloid leukemia (AML) 2. Acute lymphoblastic leukemia (ALL) 3. Intermediate or high-risk myelodysplastic syndrome (MDS), as defined by the revised International Prognostic Scoring System (IPSS-R) and/or IPSS-molecular (IPSS-M) 4. Intermediate or high-risk chronic myelomonocytic leukemia (CMML) by the CMML-specific prognostic scoring system (CPSS-Mol) 5. Patients with lower risk MDS or CMML may also be included if baseline peripheral blood labs indicate anticipated transfusion dependence, defined as needing ≥2 units of red blood cells every 28 days 6. Patients with lower risk MDS or CMML may also be included if anticipated visits with the leukemia clinic exceed once per month by primary oncologist 2\. Ability to complete surveys in English, Spanish, or with assistance of an interpreter. Exclusion Criteria: 1. Adults unable to consent due to lack of capacity based on their leukemia clinician assessment. 2. Individuals who are not yet adults (infants, children, teenagers).